CA Stock MarketDetailed Quotes

APS Aptose Biosciences Inc

Watchlist
  • 0.880
  • -0.010-1.12%
15min DelayMarket Closed Jul 23 16:00 ET
15.94MMarket Cap-106P/E (TTM)

Aptose Biosciences Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-4.08%-11.76M
-37.96%-44.59M
-7.03%-9.26M
-50.97%-10.54M
-91.61%-13.5M
-17.18%-11.3M
25.36%-32.32M
46.08%-8.65M
13.40%-6.98M
20.15%-7.05M
Net income from continuing operations
29.51%-9.64M
-22.44%-51.21M
-19.55%-11.96M
-17.08%-11.45M
-33.73%-14.13M
-19.12%-13.68M
36.01%-41.82M
58.89%-10M
13.73%-9.78M
21.57%-10.57M
Operating gains losses
--10K
----
----
----
-60.00%2K
----
385.71%20K
366.67%16K
----
350.00%5K
Depreciation and amortization
-16.79%109K
-11.74%466K
10.00%110K
-21.28%111K
-19.15%114K
-10.27%131K
-15.11%528K
-38.65%100K
-9.03%141K
-7.24%141K
Unrealized gains and losses of investment securities
75.00%-1K
----
----
-114.29%-1K
----
---4K
----
----
--7K
----
Remuneration paid in stock
-56.83%809K
-29.84%3.65M
-52.26%411K
-43.11%599K
-1.28%769K
-25.46%1.87M
-59.79%5.21M
-62.79%861K
-42.40%1.05M
-64.00%779K
Other non cashItems
40.00%28K
45.36%-312K
51.11%-329K
-125.61%-21K
141.67%58K
600.00%20K
-108.19%-571K
-109.70%-673K
1,071.43%82K
115.89%24K
Change In working capital
-971.95%-3.08M
-34.91%2.81M
137.06%2.5M
-85.28%223K
-112.34%-317K
142.94%353K
184.76%4.32M
193.28%1.06M
18.36%1.52M
3.51%2.57M
-Change in prepaid assets
-3.91%246K
50.87%261K
73.72%-385K
-96.48%29K
-48.08%311K
19.63%256K
121.79%173K
-1.60%-1.47M
4.70%825K
383.06%599K
-Change in payables and accrued expense
-2,511.54%-3.14M
-32.24%2.89M
45.30%2.94M
-66.16%355K
-124.86%-528K
114.05%130K
195.98%4.27M
2,061.17%2.02M
68.92%1.05M
-9.92%2.12M
-Change in other current assets
-177.89%-74K
-176.61%-343K
-480.90%-339K
80.44%-44K
-175.00%-55K
196.88%95K
-3,000.00%-124K
4,550.00%89K
-2,350.00%-225K
---20K
-Change in other current liabilities
10.16%-115K
----
----
12.69%-117K
66.42%-45K
10.49%-128K
----
----
3.60%-134K
---134K
Cash from discontinued investing activities
Operating cash flow
-4.08%-11.76M
-37.96%-44.59M
-7.03%-9.26M
-50.97%-10.54M
-91.61%-13.5M
-17.18%-11.3M
25.36%-32.32M
46.08%-8.65M
13.40%-6.98M
20.15%-7.05M
Investing cash flow
Cash flow from continuing investing activities
32.74%-1.99M
-66.87%9.96M
-88.97%1.94M
355.08%12.95M
-119.47%-1.96M
-139.44%-2.96M
185.40%30.07M
187.82%17.57M
-2,644.86%-5.08M
101.36%10.07M
Net PPE purchase and sale
--1K
-20.83%-29K
--0
--0
-20.83%-29K
--0
88.68%-24K
--0
--0
---24K
Net investment purchase and sale
32.70%-1.99M
-66.80%9.99M
-88.97%1.94M
355.08%12.95M
-119.14%-1.93M
-139.44%-2.96M
185.98%30.09M
187.88%17.57M
-126,850.00%-5.08M
101.84%10.09M
Cash from discontinued investing activities
Investing cash flow
32.74%-1.99M
-66.87%9.96M
-88.97%1.94M
355.08%12.95M
-119.47%-1.96M
-139.44%-2.96M
185.40%30.07M
187.82%17.57M
-2,644.86%-5.08M
101.36%10.07M
Financing cash flow
Cash flow from continuing financing activities
23,594.00%11.85M
5,856.90%6.91M
1,574.51%854K
23,242.86%4.9M
3,706.90%1.1M
233.33%50K
-48.67%116K
-22.73%51K
21K
-65.88%29K
Net common stock issuance
34,691.18%11.83M
6,712.87%6.88M
1,554.90%844K
23,204.76%4.89M
3,724.14%1.11M
--34K
180.56%101K
41.67%51K
--21K
--29K
Proceeds from stock option exercised by employees
12.50%18K
93.33%29K
--0
--13K
--0
6.67%16K
-92.11%15K
--0
--0
--0
Net other financing activities
----
----
----
---5K
---5K
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
23,594.00%11.85M
5,856.90%6.91M
1,574.51%854K
23,242.86%4.9M
3,706.90%1.1M
233.33%50K
-48.67%116K
-22.73%51K
--21K
-65.88%29K
Net cash flow
Beginning cash position
-74.97%9.25M
-5.48%36.97M
-43.84%15.72M
-79.02%8.4M
-38.47%22.76M
-5.48%36.97M
-66.68%39.11M
-62.73%27.99M
-51.96%40.03M
-57.52%36.99M
Current changes in cash
86.58%-1.91M
-1,195.33%-27.72M
-172.07%-6.47M
160.81%7.32M
-571.10%-14.36M
-568.80%-14.21M
97.27%-2.14M
124.93%8.97M
-46.00%-12.04M
181.48%3.05M
Effect of exchange rate changes
-75.00%1K
150.00%2K
-116.67%-1K
114.29%1K
40.00%-3K
100.00%4K
-157.14%-4K
-14.29%6K
-75.00%-7K
-600.00%-5K
End cash Position
-67.73%7.35M
-74.97%9.25M
-74.97%9.25M
-43.84%15.72M
-79.02%8.4M
-38.47%22.76M
-5.48%36.97M
-5.48%36.97M
-62.73%27.99M
-51.96%40.03M
Free cash from
-4.08%-11.76M
-37.94%-44.62M
-7.03%-9.26M
-50.97%-10.54M
-91.37%-13.53M
-17.18%-11.3M
25.67%-32.35M
46.13%-8.65M
15.30%-6.98M
19.88%-7.07M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -4.08%-11.76M-37.96%-44.59M-7.03%-9.26M-50.97%-10.54M-91.61%-13.5M-17.18%-11.3M25.36%-32.32M46.08%-8.65M13.40%-6.98M20.15%-7.05M
Net income from continuing operations 29.51%-9.64M-22.44%-51.21M-19.55%-11.96M-17.08%-11.45M-33.73%-14.13M-19.12%-13.68M36.01%-41.82M58.89%-10M13.73%-9.78M21.57%-10.57M
Operating gains losses --10K-------------60.00%2K----385.71%20K366.67%16K----350.00%5K
Depreciation and amortization -16.79%109K-11.74%466K10.00%110K-21.28%111K-19.15%114K-10.27%131K-15.11%528K-38.65%100K-9.03%141K-7.24%141K
Unrealized gains and losses of investment securities 75.00%-1K---------114.29%-1K-------4K----------7K----
Remuneration paid in stock -56.83%809K-29.84%3.65M-52.26%411K-43.11%599K-1.28%769K-25.46%1.87M-59.79%5.21M-62.79%861K-42.40%1.05M-64.00%779K
Other non cashItems 40.00%28K45.36%-312K51.11%-329K-125.61%-21K141.67%58K600.00%20K-108.19%-571K-109.70%-673K1,071.43%82K115.89%24K
Change In working capital -971.95%-3.08M-34.91%2.81M137.06%2.5M-85.28%223K-112.34%-317K142.94%353K184.76%4.32M193.28%1.06M18.36%1.52M3.51%2.57M
-Change in prepaid assets -3.91%246K50.87%261K73.72%-385K-96.48%29K-48.08%311K19.63%256K121.79%173K-1.60%-1.47M4.70%825K383.06%599K
-Change in payables and accrued expense -2,511.54%-3.14M-32.24%2.89M45.30%2.94M-66.16%355K-124.86%-528K114.05%130K195.98%4.27M2,061.17%2.02M68.92%1.05M-9.92%2.12M
-Change in other current assets -177.89%-74K-176.61%-343K-480.90%-339K80.44%-44K-175.00%-55K196.88%95K-3,000.00%-124K4,550.00%89K-2,350.00%-225K---20K
-Change in other current liabilities 10.16%-115K--------12.69%-117K66.42%-45K10.49%-128K--------3.60%-134K---134K
Cash from discontinued investing activities
Operating cash flow -4.08%-11.76M-37.96%-44.59M-7.03%-9.26M-50.97%-10.54M-91.61%-13.5M-17.18%-11.3M25.36%-32.32M46.08%-8.65M13.40%-6.98M20.15%-7.05M
Investing cash flow
Cash flow from continuing investing activities 32.74%-1.99M-66.87%9.96M-88.97%1.94M355.08%12.95M-119.47%-1.96M-139.44%-2.96M185.40%30.07M187.82%17.57M-2,644.86%-5.08M101.36%10.07M
Net PPE purchase and sale --1K-20.83%-29K--0--0-20.83%-29K--088.68%-24K--0--0---24K
Net investment purchase and sale 32.70%-1.99M-66.80%9.99M-88.97%1.94M355.08%12.95M-119.14%-1.93M-139.44%-2.96M185.98%30.09M187.88%17.57M-126,850.00%-5.08M101.84%10.09M
Cash from discontinued investing activities
Investing cash flow 32.74%-1.99M-66.87%9.96M-88.97%1.94M355.08%12.95M-119.47%-1.96M-139.44%-2.96M185.40%30.07M187.82%17.57M-2,644.86%-5.08M101.36%10.07M
Financing cash flow
Cash flow from continuing financing activities 23,594.00%11.85M5,856.90%6.91M1,574.51%854K23,242.86%4.9M3,706.90%1.1M233.33%50K-48.67%116K-22.73%51K21K-65.88%29K
Net common stock issuance 34,691.18%11.83M6,712.87%6.88M1,554.90%844K23,204.76%4.89M3,724.14%1.11M--34K180.56%101K41.67%51K--21K--29K
Proceeds from stock option exercised by employees 12.50%18K93.33%29K--0--13K--06.67%16K-92.11%15K--0--0--0
Net other financing activities ---------------5K---5K--------------------
Cash from discontinued financing activities
Financing cash flow 23,594.00%11.85M5,856.90%6.91M1,574.51%854K23,242.86%4.9M3,706.90%1.1M233.33%50K-48.67%116K-22.73%51K--21K-65.88%29K
Net cash flow
Beginning cash position -74.97%9.25M-5.48%36.97M-43.84%15.72M-79.02%8.4M-38.47%22.76M-5.48%36.97M-66.68%39.11M-62.73%27.99M-51.96%40.03M-57.52%36.99M
Current changes in cash 86.58%-1.91M-1,195.33%-27.72M-172.07%-6.47M160.81%7.32M-571.10%-14.36M-568.80%-14.21M97.27%-2.14M124.93%8.97M-46.00%-12.04M181.48%3.05M
Effect of exchange rate changes -75.00%1K150.00%2K-116.67%-1K114.29%1K40.00%-3K100.00%4K-157.14%-4K-14.29%6K-75.00%-7K-600.00%-5K
End cash Position -67.73%7.35M-74.97%9.25M-74.97%9.25M-43.84%15.72M-79.02%8.4M-38.47%22.76M-5.48%36.97M-5.48%36.97M-62.73%27.99M-51.96%40.03M
Free cash from -4.08%-11.76M-37.94%-44.62M-7.03%-9.26M-50.97%-10.54M-91.37%-13.53M-17.18%-11.3M25.67%-32.35M46.13%-8.65M15.30%-6.98M19.88%-7.07M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion with Explanatory Notes------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
%Chg